<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Asthma Management Algorithm - NICE CKS</title>
<style>
* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

body {
  font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
  background: #f5f7fa;
  color: #2c3e50;
  line-height: 1.6;
}

.header {
  background: linear-gradient(135deg, #1e5799 0%, #207cca 100%);
  color: white;
  padding: 25px 20px;
  text-align: center;
  box-shadow: 0 4px 12px rgba(0,0,0,0.1);
}

.header h1 {
  font-size: 2.2em;
  margin-bottom: 10px;
}

.header p {
  font-size: 1.1em;
  opacity: 0.9;
}

.container {
  display: flex;
  max-width: 1400px;
  margin: 0 auto;
}

.sidebar {
  position: sticky;
  top: 20px;
  width: 280px;
  height: fit-content;
  background: white;
  margin: 20px 20px 20px 10px;
  border-radius: 12px;
  box-shadow: 0 4px 15px rgba(0,0,0,0.08);
  padding: 20px;
}

.sidebar h3 {
  color: #1e5799;
  margin-bottom: 20px;
  font-size: 1.3em;
  border-bottom: 2px solid #e3f2fd;
  padding-bottom: 10px;
}

.progress-item {
  display: flex;
  align-items: center;
  padding: 12px;
  margin: 8px 0;
  border-radius: 8px;
  cursor: pointer;
  transition: all 0.3s ease;
  font-weight: 500;
}

.progress-item:hover {
  background: #e3f2fd;
  transform: translateX(5px);
}

.progress-item.active {
  background: #1e5799;
  color: white;
}

.progress-icon {
  width: 24px;
  height: 24px;
  margin-right: 12px;
  background-size: contain;
}

.main-content {
  flex: 1;
  padding: 20px;
}

.step-card {
  background: white;
  border-radius: 12px;
  margin-bottom: 25px;
  box-shadow: 0 4px 15px rgba(0,0,0,0.08);
  overflow: hidden;
  transition: transform 0.3s ease, box-shadow 0.3s ease;
}

.step-card:hover {
  transform: translateY(-5px);
  box-shadow: 0 8px 25px rgba(0,0,0,0.12);
}

.step-header {
  display: flex;
  align-items: center;
  padding: 25px;
  cursor: pointer;
  transition: all 0.3s ease;
}

.assessment .step-header { background: linear-gradient(135deg, #2196F3, #1976D2); }
.diagnosis .step-header { background: linear-gradient(135deg, #9C27B0, #7B1FA2); }
.treatment .step-header { background: linear-gradient(135deg, #4CAF50, #388E3C); }
.followup .step-header { background: linear-gradient(135deg, #FF9800, #F57C00); }

.step-icon {
  width: 50px;
  height: 50px;
  background: white;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-size: 24px;
  margin-right: 20px;
}

.assessment .step-icon { color: #2196F3; }
.diagnosis .step-icon { color: #9C27B0; }
.treatment .step-icon { color: #4CAF50; }
.followup .step-icon { color: #FF9800; }

.step-title h2 {
  color: white;
  font-size: 1.8em;
  margin-bottom: 5px;
}

.step-title p {
  color: rgba(255,255,255,0.9);
  font-size: 0.95em;
}

.expand-icon {
  margin-left: auto;
  color: white;
  font-size: 28px;
  transition: transform 0.3s ease;
}

.step-card.expanded .expand-icon {
  transform: rotate(180deg);
}

.step-content {
  padding: 0 25px;
  max-height: 0;
  overflow: hidden;
  transition: max-height 0.5s ease, padding 0.5s ease;
}

.step-card.expanded .step-content {
  padding: 25px;
  max-height: 2000px;
}

.section {
  margin-bottom: 25px;
  padding-bottom: 20px;
  border-bottom: 1px solid #e0e0e0;
}

.section:last-child {
  border-bottom: none;
  margin-bottom: 0;
  padding-bottom: 0;
}

.section h3 {
  color: #2c3e50;
  margin-bottom: 15px;
  font-size: 1.3em;
  display: flex;
  align-items: center;
}

.age-group {
  background: #f8f9fa;
  border-left: 4px solid #1e5799;
  padding: 15px;
  margin: 15px 0;
  border-radius: 0 8px 8px 0;
}

.age-group h4 {
  color: #1e5799;
  margin-bottom: 10px;
  font-size: 1.1em;
}

ul {
  margin-left: 25px;
  margin-bottom: 15px;
}

li {
  margin-bottom: 8px;
}

.severity-badge {
  display: inline-block;
  padding: 6px 12px;
  border-radius: 20px;
  font-size: 0.85em;
  font-weight: 600;
  margin: 5px 5px 5px 0;
  box-shadow: 0 2px 4px rgba(0,0,0,0.1);
}

.badge-red {
  background: linear-gradient(135deg, #f44336, #d32f2f);
  color: white;
}

.badge-amber {
  background: linear-gradient(135deg, #FF9800, #F57C00);
  color: white;
}

.badge-green {
  background: linear-gradient(135deg, #4CAF50, #388E3C);
  color: white;
}

.alert-box {
  padding: 15px;
  border-radius: 8px;
  margin: 15px 0;
  border-left: 4px solid;
}

.alert-red {
  background: #ffebee;
  border-left-color: #f44336;
}

.alert-amber {
  background: #fff3e0;
  border-left-color: #FF9800;
}

.alert-green {
  background: #e8f5e8;
  border-left-color: #4CAF50;
}

.treatment-step {
  background: white;
  border: 2px solid #e3f2fd;
  border-radius: 8px;
  padding: 15px;
  margin: 15px 0;
}

.treatment-step h4 {
  color: #1e5799;
  margin-bottom: 10px;
}

.medication-table {
  width: 100%;
  border-collapse: collapse;
  margin: 15px 0;
  font-size: 0.9em;
}

.medication-table th,
.medication-table td {
  border: 1px solid #ddd;
  padding: 10px;
  text-align: left;
}

.medication-table th {
  background: #e3f2fd;
  font-weight: 600;
}

.medication-table tr:nth-child(even) {
  background: #f9f9f9;
}

.exacerbation-level {
  padding: 15px;
  margin: 10px 0;
  border-radius: 8px;
  border-left: 4px solid;
}

.life-threatening {
  background: #ffebee;
  border-left-color: #f44336;
}

.acute-severe {
  background: #fff3e0;
  border-left-color: #FF9800;
}

.moderate {
  background: #e8f5e8;
  border-left-color: #4CAF50;
}

@media (max-width: 768px) {
  .container {
    flex-direction: column;
  }
  
  .sidebar {
    position: relative;
    width: 100%;
    margin: 10px;
  }
  
  .main-content {
    padding: 10px;
  }
  
  .step-header {
    padding: 20px;
  }
  
  .step-icon {
    width: 40px;
    height: 40px;
    font-size: 20px;
    margin-right: 15px;
  }
  
  .step-title h2 {
    font-size: 1.5em;
  }
}
</style>
</head>
<body>
<div class="header">
  <h1>Asthma Management Algorithm</h1>
  <p>Primary Care Decision Support Tool | NICE CKS Guidelines (May 2025)</p>
</div>

<div class="container">
  <div class="sidebar">
    <h3>Algorithm Progress</h3>
    <div class="progress-item active" data-step="assessment">
      <div class="progress-icon">üìã</div>
      <span>Assessment</span>
    </div>
    <div class="progress-item" data-step="diagnosis">
      <div class="progress-icon">üîç</div>
      <span>Diagnosis</span>
    </div>
    <div class="progress-item" data-step="treatment">
      <div class="progress-icon">üíä</div>
      <span>Treatment</span>
    </div>
    <div class="progress-item" data-step="followup">
      <div class="progress-icon">üîÑ</div>
      <span>Follow-up</span>
    </div>
  </div>

  <div class="main-content">
    <!-- Assessment Section -->
    <div class="step-card assessment" id="assessment">
      <div class="step-header" onclick="toggleCard('assessment')">
        <div class="step-icon">üìã</div>
        <div class="step-title">
          <h2>Assessment</h2>
          <p>Comprehensive evaluation of suspected asthma</p>
        </div>
        <div class="expand-icon">‚ñº</div>
      </div>
      <div class="step-content">
        <div class="section">
          <h3>ü©∫ Clinical History</h3>
          <p><strong>Key Symptoms:</strong> Wheeze, noisy breathing, cough, breathlessness, chest tightness</p>
          <ul>
            <li>Episodic and variable pattern (worse at night, early morning, seasonal)</li>
            <li>Triggers: exercise, viral infections, allergens, temperature changes, NSAIDs, beta-blockers</li>
            <li>Impact on daily activities, school/work attendance</li>
            <li>Previous diagnoses or hospital admissions</li>
          </ul>
        </div>

        <div class="section">
          <h3>‚ö†Ô∏è Risk Factors & Triggers</h3>
          <div class="alert-box alert-amber">
            <strong>Atopy:</strong> Personal/family history of asthma, eczema, allergic rhinitis, nasal polyps
          </div>
          <ul>
            <li>Comorbid rhinitis/sinusitis (10-40% have asthma)</li>
            <li>Food allergy (4x increased risk in children)</li>
            <li>Smoking (active/passive including e-cigarettes)</li>
            <li>Environmental: pollution, moulds, occupational exposure</li>
            <li>Obesity (difficult to control)</li>
            <li>Viral respiratory tract infections</li>
          </ul>
          <span class="severity-badge badge-amber">Occupational asthma: 1 in 6 adult cases</span>
        </div>

        <div class="section">
          <h3>üëÅÔ∏è Examination</h3>
          <ul>
            <li><strong>Vital signs:</strong> Temperature, SpO‚ÇÇ, RR, HR, accessory muscle use</li>
            <li><strong>Chest:</strong> Expiratory polyphonic wheeze (may be absent)</li>
            <li><strong>Nose:</strong> Allergic rhinitis, nasal polyps</li>
            <li><strong>Growth:</strong> Height, weight, BMI (children)</li>
            <li><strong>Alert:</strong> Normal exam does NOT exclude asthma</li>
          </ul>
        </div>

        <div class="section">
          <h3>üß™ Objective Tests</h3>
          <div class="age-group">
            <h4>Adults & Young People (‚â•16 years)</h4>
            <ol>
              <li><strong>Blood eosinophils or FeNO:</strong> 
                <ul>
                  <li>Eosinophils > lab range OR FeNO ‚â•50 ppb ‚Üí <span class="severity-badge badge-green">Diagnose asthma</span></li>
                </ul>
              </li>
              <li><strong>If normal:</strong> Bronchodilator reversibility (BDR)
                <ul>
                  <li>FEV‚ÇÅ increase ‚â•12% AND ‚â•200mL ‚Üí <span class="severity-badge badge-green">Diagnose asthma</span></li>
                </ul>
              </li>
              <li><strong>If unavailable:</strong> PEF twice daily for 2 weeks
                <ul>
                  <li>Variability ‚â•20% ‚Üí <span class="severity-badge badge-green">Diagnose asthma</span></li>
                </ul>
              </li>
              <li><strong>Still uncertain:</strong> Specialist referral for bronchial challenge test</li>
            </ol>
          </div>

          <div class="age-group">
            <h4>Children (5-16 years)</h4>
            <ol>
              <li><strong>FeNO:</strong> FeNO ‚â•35 ppb ‚Üí <span class="severity-badge badge-green">Diagnose asthma</span></li>
              <li><strong>If normal/unavailable:</strong> BDR with spirometry
                <ul>
                  <li>FEV‚ÇÅ increase ‚â•12% ‚Üí <span class="severity-badge badge-green">Diagnose asthma</span></li>
                </ul>
              </li>
              <li><strong>If unavailable:</strong> PEF twice daily for 2 weeks (variability ‚â•20%)</li>
              <li><strong>Still uncertain:</strong> Skin prick testing to house dust mite OR total IgE + eosinophils</li>
            </ol>
          </div>

          <div class="age-group">
            <h4>Children Under 5 years</h4>
            <p>Diagnosis is challenging - no good reference standards</p>
            <ul>
              <li>Trial of low-dose ICS twice daily for 8-12 weeks</li>
              <li>Reassess response and symptoms</li>
              <li>Arrange objective testing at age 5 years</li>
            </ul>
          </div>
        </div>
      </div>
    </div>

    <!-- Diagnosis Section -->
    <div class="step-card diagnosis" id="diagnosis">
      <div class="step-header" onclick="toggleCard('diagnosis')">
        <div class="step-icon">üîç</div>
        <div class="step-title">
          <h2>Diagnosis</h2>
          <p>Confirm diagnosis and rule out differentials</p>
        </div>
        <div class="expand-icon">‚ñº</div>
      </div>
      <div class="step-content">
        <div class="section">
          <h3>üéØ Diagnostic Criteria</h3>
          <div class="alert-box alert-green">
            <strong>Asthma is likely if:</strong> Suggestive clinical history + supportive objective test
          </div>
          <ul>
            <li>Variable respiratory symptoms + variable expiratory airflow limitation</li>
            <li>Symptoms resolve spontaneously or with medication</li>
            <li>Code as 'suspected asthma' until diagnosis confirmed</li>
          </ul>
        </div>

        <div class="section">
          <h3>üíº Occupational Asthma</h3>
          <span class="severity-badge badge-red">Suspect if:</span>
          <ul>
            <li>Working age adult with NEW asthma symptoms</li>
            <li>Reappearance of childhood asthma</li>
            <li>Deteriorating control</li>
            <li>Symptoms better away from work/on holiday</li>
            <li>Employed in high-risk job (baking, healthcare, spray painting, welding, etc.)</li>
          </ul>
        </div>

        <div class="section">
          <h3>üö´ Differential Diagnosis</h3>
          <div class="treatment-step">
            <h4>Adult Considerations</h4>
            <ul>
              <li><strong>COPD:</strong> Age >35, >30 pack-years smoking, fixed airflow obstruction</li>
              <li><strong>Heart failure:</strong> Orthopnea, PND, peripheral edema, cardiac history</li>
              <li><strong>Bronchiectasis:</strong> Persistent productive cough, recurrent infections, finger clubbing</li>
              <li><strong>Lung cancer:</strong> Persistent cough, hemoptysis, weight loss, smoking history</li>
              <li><strong>Pulmonary embolism:</strong> Acute onset, pleuritic pain, hemoptysis</li>
              <li><strong>Vocal cord dysfunction:</strong> Recurrent 'exacerbations' without objective evidence</li>
            </ul>
          </div>

          <div class="treatment-step">
            <h4>Child Considerations</h4>
            <ul>
              <li><strong>Recurrent viral RTI:</strong> Cough <10 days, asymptomatic between infections</li>
              <li><strong>Gastro-oesophageal reflux:</strong> Postural symptoms, vomiting, faltering growth</li>
              <li><strong>Cystic fibrosis:</strong> Persistent moist cough, GI symptoms from birth, finger clubbing</li>
              <li><strong>Primary ciliary dyskinesia:</strong> Recurrent infections, chronic ear disease, situs inversus</li>
              <li><strong>Inhaled foreign body:</strong> Sudden onset, unilateral wheeze, stridor</li>
            </ul>
          </div>
        </div>

        <div class="section">
          <h3>‚ö†Ô∏è Red Flags for Alternative Diagnosis</h3>
          <div class="alert-box alert-red">
            <ul>
              <li>Prominent systemic features (fever, weight loss, night sweats)</li>
              <li>Hemoptysis, finger clubbing, cyanosis</li>
              <li>Focal chest signs or persistent chest X-ray changes</li>
              <li>Symptoms present from birth or perinatal lung problems</li>
              <li>Faltering growth (children)</li>
            </ul>
          </div>
          <span class="severity-badge badge-red">Consider specialist referral</span>
        </div>
      </div>
    </div>

    <!-- Treatment Section -->
    <div class="step-card treatment" id="treatment">
      <div class="step-header" onclick="toggleCard('treatment')">
        <div class="step-icon">üíä</div>
        <div class="step-title">
          <h2>Treatment</h2>
          <p>Stepwise pharmacological management</p>
        </div>
        <div class="expand-icon">‚ñº</div>
      </div>
      <div class="step-content">
        <div class="section">
          <h3>üéØ Treatment Principles</h3>
          <ul>
            <li>All patients with asthma require ICS-containing therapy</li>
            <li>Do NOT prescribe SABA alone (without ICS)</li>
            <li>Individualize inhaler choice based on technique, preference, environmental impact</li>
            <li>Provide personalized asthma action plan</li>
            <li>Address modifiable risk factors</li>
          </ul>
        </div>

        <div class="section">
          <h3>üë• Adults & Young People (‚â•12 years)</h3>
          <div class="treatment-step">
            <h4>Step 1: Initial Treatment</h4>
            <span class="severity-badge badge-green">As-needed anti-inflammatory reliever (AIR) therapy</span>
            <ul>
              <li>Low-dose ICS/formoterol combination inhaler taken as needed for symptom relief</li>
              <li>Examples: Symbicort, Fostair, DuoResp, Fobumix, Luforbec, Wockair</li>
              <li>Use before exercise or allergen exposure if needed</li>
            </ul>
          </div>

          <div class="treatment-step">
            <h4>Step 2: If Highly Symptomatic or Uncontrolled</h4>
            <span class="severity-badge badge-amber">Low-dose MART (Maintenance And Reliever Therapy)</span>
            <ul>
              <li>Same ICS/formoterol inhaler for daily maintenance + as-needed relief</li>
              <li>Continue regular maintenance dose, increase reliever doses as needed</li>
              <li>Maximum daily licensed dose must not be exceeded</li>
            </ul>
          </div>

          <div class="treatment-step">
            <h4>Step 3: If Still Uncontrolled</h4>
            <span class="severity-badge badge-amber">Moderate-dose MART</span>
          </div>

          <div class="treatment-step">
            <h4>Step 4: Add-on Therapies (if eosinophils/FeNO raised)</h4>
            <ul>
              <li>Add LTRA (montelukast 10mg nocte) for 8-12 weeks</li>
              <li>OR add LAMA (tiotropium 5mcg daily) for 8-12 weeks</li>
              <li>If improved but inadequate: continue and add other agent</li>
              <li>If no improvement: stop and try alternative</li>
            </ul>
          </div>

          <div class="treatment-step">
            <h4>Step 5: Specialist Referral</h4>
            <span class="severity-badge badge-red">If uncontrolled on moderate-dose MART + LTRA + LAMA</span>
          </div>
        </div>

        <div class="section">
          <h3>üë∂ Children (5-11 years)</h3>
          <div class="treatment-step">
            <h4>Initial Treatment</h4>
            <span class="severity-badge badge-green">Twice-daily paediatric low-dose ICS + SABA as needed</span>
            <ul>
              <li>Examples: beclometasone 100-200mcg/day, budesonide 200mcg/day</li>
            </ul>
          </div>

          <div class="treatment-step">
            <h4>If Uncontrolled: Option 1 - MART (off-label)</h4>
            <span class="severity-badge badge-amber">Consider paediatric low-dose MART if child can manage</span>
            <ul>
              <li>Use ICS/formoterol combination inhaler</li>
              <li>If still uncontrolled: increase to paediatric moderate-dose MART</li>
            </ul>
          </div>

          <div class="treatment-step">
            <h4>If Uncontrolled: Option 2 - Conventional</h4>
            <ul>
              <li>Add LTRA (montelukast 5mg nocte) for 8-12 weeks</li>
              <li>If ineffective: stop LTRA</li>
              <li>Escalate to low-dose ICS/LABA combination inhaler</li>
              <li>If still uncontrolled: moderate-dose ICS/LABA</li>
            </ul>
          </div>

          <div class="treatment-step">
            <h4>Specialist Referral</h4>
            <span class="severity-badge badge-red">If uncontrolled on moderate-dose therapy</span>
          </div>
        </div>

        <div class="section">
          <h3>üë∂ Children Under 5 years</h3>
          <div class="alert-box alert-amber">
            <strong>Trial of Treatment:</strong> 8-12 weeks of twice-daily paediatric low-dose ICS
          </div>
          <ul>
            <li>Indications: Interval symptoms with atopic disorder OR severe acute episodes</li>
            <li>If symptoms resolve: consider stopping and review after 3 months</li>
            <li>If symptoms recur: restart and titrate up to moderate-dose</li>
            <li>If uncontrolled on moderate-dose: add LTRA or refer to specialist</li>
          </ul>
        </div>

        <div class="section">
          <h3>üìù Personalised Asthma Action Plan</h3>
          <div class="alert-box alert-green">
            <strong>Essential Components:</strong>
            <ul>
              <li>Individual triggers and avoidance strategies</li>
              <li>Recognition of early exacerbation signs</li>
              <li>Specific instructions for medication changes</li>
              <li>When and how to use oral prednisolone</li>
              <li>When to seek urgent medical attention</li>
              <li>PEF monitoring (if used, document personal best)</li>
            </ul>
          </div>
          <p>Resources: Asthma and Lung UK (www.asthmaandlung.org.uk), Beat Asthma (www.beatasthma.co.uk)</p>
        </div>

        <div class="section">
          <h3>üí® Inhaler Devices</h3>
          <ul>
            <li><strong>Prescribe spacer with pMDI</strong> (especially children)</li>
            <li>Check technique at EVERY consultation and review</li>
            <li>Consider alternatives if technique poor after training</li>
            <li>Avoid mixing pMDI and DPI for same patient</li>
            <li>Consider environmental impact (DPIs have lower carbon footprint)</li>
          </ul>
        </div>

        <div class="section">
          <h3>üõ°Ô∏è Self-Care Measures</h3>
          <ul>
            <li>Smoking cessation (active & passive)</li>
            <li>Weight management if overweight/obese</li>
            <li>Regular physical activity (use reliever before exercise)</li>
            <li>Manage comorbidities (rhinitis, reflux, anxiety/depression)</li>
            <li>Ensure up-to-date vaccinations (influenza, pneumococcal)</li>
          </ul>
        </div>
      </div>
    </div>

    <!-- Follow-up Section -->
    <div class="step-card followup" id="followup">
      <div class="step-header" onclick="toggleCard('followup')">
        <div class="step-icon">üîÑ</div>
        <div class="step-title">
          <h2>Follow-up & Acute Exacerbation</h2>
          <p>Monitoring, stepping therapy & emergency management</p>
        </div>
        <div class="expand-icon">‚ñº</div>
      </div>
      <div class="step-content">
        <div class="section">
          <h3>üìÖ Routine Follow-up</h3>
          <div class="alert-box alert-green">
            <strong>Frequency:</strong> At least annually and after any exacerbation
          </div>
          
          <h4>Key Assessment Points:</h4>
          <ul>
            <li><strong>Symptoms:</strong> Day/night symptoms, impact on activities, triggers</li>
            <li><strong>Control indicators:</strong>
              <ul>
                <li>SABA use: >2 inhalers/year ‚Üí poor control</li>
                <li>Oral corticosteroids: ‚â•2 courses/year ‚Üí poor control</li>
                <li>Hospital/ED attendance: ‚â•2 visits/year ‚Üí poor control</li>
              </ul>
            </li>
            <li><strong>Technique & adherence:</strong> Check at every review</li>
            <li><strong>Inhaler over-ordering:</strong> Suggests poor control or overuse</li>
            <li><strong>Adverse effects:</strong> Faltering growth (children), oral thrush</li>
            <li><strong>Comorbidities:</strong> Rhinitis, reflux, obesity, anxiety/depression</li>
            <li><strong>Modifiable risk factors:</strong> Smoking, occupational exposure</li>
            <li><strong>Validated questionnaires:</strong> ACT, ACQ, C-ACT</li>
          </ul>
        </div>

        <div class="section">
          <h3>üìà Stepping Up Treatment</h3>
          <div class="alert-box alert-amber">
            <strong>Consider if:</strong> Symptoms remain uncontrolled after addressing risk factors
          </div>
          <ul>
            <li>Review response after 8-12 weeks</li>
            <li>Escalate according to age-specific treatment steps</li>
            <li>Check adherence and technique before escalating</li>
          </ul>
        </div>

        <div class="section">
          <h3>üìâ Stepping Down Treatment</h3>
          <div class="alert-box alert-green">
            <strong>If well controlled for 8-12 weeks:</strong> Consider step-down at annual review
          </div>
          <ul>
            <li>Discuss risks and benefits</li>
            <li>Step down to lowest dose that controls symptoms</li>
            <li>For ‚â•12 years on low-dose ICS + SABA: consider as-needed AIR therapy</li>
            <li>Allow 8-12 weeks before further reduction</li>
            <li>Update action plan</li>
            <li>Monitor and review regularly</li>
          </ul>
        </div>

        <div class="section">
          <h3>ü§∞ Pregnancy</h3>
          <div class="alert-box alert-amber">
            <strong>Key Points:</strong>
            <ul>
              <li>Review in early pregnancy and post-partum</li>
              <li>Maintain good control - do NOT stop ICS/LABA</li>
              <li>Continue LTRA/LAMA if needed</li>
              <li>OCS for acute exacerbations - benefits outweigh risks</li>
            </ul>
          </div>
        </div>

        <div class="section">
          <h3>üè• Acute Exacerbation Management</h3>
          <p><strong>Assessment of Severity:</strong></p>
          
          <div class="exacerbation-level life-threatening">
            <h4>üö® Life-threatening (Any one of):</h4>
            <ul>
              <li>Cyanosis, drowsiness, confusion, exhaustion</li>
              <li>Poor respiratory effort, 'silent chest'</li>
              <li>SpO‚ÇÇ <92%, hypotension</li>
              <li>PEF <33% best/predicted</li>
            </ul>
            <span class="severity-badge badge-red">EMERGENCY TREATMENT + HOSPITAL ADMISSION</span>
          </div>

          <div class="exacerbation-level acute-severe">
            <h4>‚ö†Ô∏è Acute Severe (Any one of):</h4>
            <p><strong>Adults:</strong> Can't complete sentences, SpO‚ÇÇ <92%, RR >25, HR >110, PEF 33-50%</p>
            <p><strong>Children:</strong> Too breathless to talk/feed, accessory muscles, SpO‚ÇÇ <92%, PEF 33-50%</p>
            <span class="severity-badge badge-red">HOSPITAL ADMISSION</span>
          </div>

          <div class="exacerbation-level moderate">
            <h4>‚úÖ Moderate:</h4>
            <p>Talking in sentences, SpO‚ÇÇ ‚â•92%, no severe features</p>
            <span class="severity-badge badge-amber">MANAGE IN PRIMARY CARE, REVIEW RESPONSE</span>
          </div>

          <h4>Treatment Protocol:</h4>
          <table class="medication-table">
            <tr>
              <th>Drug</th>
              <th>Dose (Adults)</th>
              <th>Dose (Children)</th>
              <th>Route</th>
            </tr>
            <tr>
              <td>Salbutamol</td>
              <td>5mg</td>
              <td>2.5mg (2-5y), 5mg (>5y)</td>
              <td>Nebuliser (oxygen-driven)</td>
            </tr>
            <tr>
              <td>Ipratropium</td>
              <td>0.5mg</td>
              <td>0.25mg (2-12y)</td>
              <td>Nebuliser (if inadequate response)</td>
            </tr>
            <tr>
              <td>Prednisolone</td>
              <td>40-50mg</td>
              <td>10-40mg (age-based)</td>
              <td>Oral (IM/IV if unable)</td>
            </tr>
          </table>

          <h4>If Managing at Home (Moderate Exacerbation):</h4>
          <ul>
            <li><strong>If on AIR/MART:</strong> Continue maintenance, increase reliever doses (max licensed dose)</li>
            <li><strong>If on low-dose ICS:</strong> Consider quadrupling dose for up to 7 days (adults)</li>
            <li>PMDI + spacer: 1 puff every 60 seconds up to 10 puffs, repeat after 10 minutes if needed</li>
            <li>Continue OCS until recovery (minimum 5 days adults, 3-5 days children)</li>
            <li>No tapering if <2 weeks</li>
            <li>Continue ICS when taking OCS</li>
          </ul>
          <span class="severity-badge badge-red">Ring 999 if needing frequent reliever doses without improvement</span>
        </div>

        <div class="section">
          <h3>üìû Post-Exacerbation Review</h3>
          <div class="alert-box alert-red">
            <strong>Review within 2 working days of discharge</strong>
          </div>
          <ul>
            <li>Assess symptom resolution</li>
            <li>Check inhaler technique and adherence</li>
            <li>Identify and manage triggers</li>
            <li>Update personalized asthma action plan</li>
            <li>Consider prescribing rescue OCS course for home</li>
          </ul>
        </div>

        <div class="section">
          <h3>üö® Specialist Referral Criteria</h3>
          <div class="alert-box alert-red">
            <span class="severity-badge badge-red">URGENT REFERRAL:</span> Near-fatal asthma, life-threatening exacerbation
          </div>
          
          <h4>Routine Referral:</h4>
          <ul>
            <li>Diagnostic uncertainty (adults or children)</li>
            <li>Suspected occupational asthma ‚Üí occupational lung disease service (within 6 weeks)</li>
            <li>Persistent symptoms/exacerbations despite optimized treatment for 3-6 months</li>
            <li>Severe asthma, difficult-to-treat asthma</li>
            <li>Asthma + COPD overlap</li>
            <li>Child <5 unable to perform tests and not responding to treatment</li>
            <li>Preschool child: hospital admission OR ‚â•2 ED visits in 12 months</li>
            <li>Child with food allergy/anaphylaxis + asthma</li>
            <li>Significant adverse effects (faltering growth)</li>
          </ul>
        </div>

        <div class="section">
          <h3>üìä QOF Indicators 2025-2026</h3>
          <div class="treatment-step">
            <p><strong>AST012:</strong> New asthma diagnosis with objective test (3 months before/after) - 15 points (45-80%)</p>
            <p><strong>AST007:</strong> Annual asthma review including control assessment, exacerbations, inhaler technique, written action plan - 20 points (45-70%)</p>
            <p><strong>SMOK002:</strong> Smoking status recorded annually - 25 points (50-90%)</p>
          </div>
        </div>
      </div>
    </div>
  </div>
</div>

<script>
// Card toggle functionality
function toggleCard(cardId) {
  const card = document.getElementById(cardId);
  const isExpanded = card.classList.contains('expanded');
  const allCards = document.querySelectorAll('.step-card');
  const progressItems = document.querySelectorAll('.progress-item');
  
  // Toggle current card
  if (isExpanded) {
    card.classList.remove('expanded');
  } else {
    // Close all other cards
    allCards.forEach(c => c.classList.remove('expanded'));
    // Open clicked card
    card.classList.add('expanded');
    
    // Scroll to card
    setTimeout(() => {
      card.scrollIntoView({ 
        behavior: 'smooth', 
        block: 'start' 
      });
    }, 100);
  }
  
  // Highlight active progress item
  progressItems.forEach(item => {
    if (item.dataset.step === cardId) {
      if (!isExpanded) {
        item.classList.add('active');
      } else {
        item.classList.remove('active');
      }
    }
  });
}

// Progress sidebar navigation
document.querySelectorAll('.progress-item').forEach(item => {
  item.addEventListener('click', function() {
    const step = this.dataset.step;
    const targetCard = document.getElementById(step);
    
    // Close all cards
    document.querySelectorAll('.step-card').forEach(card => {
      card.classList.remove('expanded');
    });
    
    // Open target card
    targetCard.classList.add('expanded');
    
    // Update active states
    document.querySelectorAll('.progress-item').forEach(p => p.classList.remove('active'));
    this.classList.add('active');
    
    // Smooth scroll
    setTimeout(() => {
      targetCard.scrollIntoView({ 
        behavior: 'smooth', 
        block: 'start' 
      });
    }, 100);
  });
});

// Expand first card by default
document.addEventListener('DOMContentLoaded', function() {
  setTimeout(() => {
    document.getElementById('assessment').classList.add('expanded');
  }, 300);
});
</script>
</body>
</html>